2型糖尿病和胃肠道癌症:风险关联和对查挑战的认识
Monika Storman1, Leszek Czupryniak2
1Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, 02-097 Warsaw, Poland.
2型糖尿病 (T2D) 增加了胃肠道 (GI) 癌症的风险. 需要新的临床策略来监测新诊断T2D患者的胃肠道癌症.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 2型糖尿病 (T2D) 越来越多地与胃肠道 (GI) 癌症的更高风险有关.
- 共同的风险因素和生物机制可能是这种关联的基础.
研究的目的:
- 审查有关T2D和胃肠道恶性瘤的证据.
- 提出一种临床框架,用于对T2D患者的风险适应的癌症警.
主要方法:
- 叙事文学评论. 叙事文学评论. 叙事文学评论. 叙事文学评论.
- 专注于T2D中的结直肠,胰腺,肝脏,胃和胆道癌.
- 检查共享的风险因素,生物机制和病理生理学.
主要成果:
- 慢性高血糖,高胰岛素,胰岛素抵抗,炎症和肠道微生物群的变化都与T2D相关的癌症发展有关.
- 目前的胃肠道癌查指南缺乏针对T2D的具体建议.
结论:
- 二型糖尿病是几种胃肠道恶性瘤的新兴风险因素.
- 临床医生应考虑针对新诊断T2D患者进行个性化肠胃肠道癌症风险评估.
- 需要进一步的研究和前性研究来评估有针对性的查策略.
更多相关视频
03:05Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Psychoneuroimmunology: Diabetes and Cancer
Diabetes: Symptoms, Diagnosis, and Complications
Cancer Prevention
Some...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
